Skip to content

NewBreez Safety and Efficacy Evaluation

Safety and Efficacy Evaluation of the NewBreez Intra-laryngeal Prosthesis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01587664
Enrollment
2
Registered
2012-04-30
Start date
2012-05-31
Completion date
2014-12-31
Last updated
2017-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Swallowing Disorders

Keywords

Swallowing disorders, Aspiration

Brief summary

The objective of this clinical study is to evaluate the safety and efficacy of the NewBreez intra-laryngeal implant in patients with dysfunctional larynx.

Interventions

DEVICENewBreez ILP

NewBreez ILP implantation

Sponsors

ProTiP Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years old 2. Congenital or acquired, central or peripheral, neurological or neuromuscular disorder associated with laryngeal dysfunction with aspirations 3. Has a tracheotomy or tracheostomy and is indicated for use of a hood weaning kit 4. Must be able to comply with all study requirements for the duration of the study as outlined in the protocol. This includes complying with the visit schedule as well as study specific procedures such as: scanner, radiographic swallowing study, nasopharyngoscopy , NewBreez ILP implant as well as quality-of-life evaluation 5. Must be able to understand and be willing to provide written informed consent

Exclusion criteria

1. Any condition that precludes the insertion of the NewBreez ILP or ancillary implantation device 2. Major swallowing disorder 3. Existing coagulation disorder 4. Previous esophageal stenting 5. Life-expectancy \< 12 months 6. Be pregnant or breastfeeding or intention of becoming pregnant during the study (if female of childbearing potential)Point of enrollment

Design outcomes

Primary

MeasureTime frameDescription
Aspiration score at 1 month1 monthWithin-subject relative change-from-baseline at 1 month in aspiration score based on radiographic swallowing study

Countries

Belgium, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026